Envoy Medical, Inc. (COCH)
USD 1.71
(-10.0%)
USD 1.71
(-10.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -17.65 Million | -8.8 Million | -6.93 Million |
| Net Income | -29.9 Million | -15.92 Million | -8.67 Million |
| Depreciation & Amortization | 133 Thousand | 75 Thousand | 71 Thousand |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 1.57 Million | - | - |
| Change in working capital | -958 Thousand | -160 Thousand | -82 Thousand |
| Other non-cash items | 13 Million | 7.2 Million | 1.75 Million |
| Investing Cash Flow | -153 Thousand | -218 Thousand | -125 Thousand |
| Investments in PPE | -153 Thousand | -218 Thousand | -125 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | - | - | -425 Million |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | - | - | 425 Million |
| Financing Cash Flow | 21.84 Million | 8.09 Million | 8.05 Million |
| Debt repayment | -10 Million | -8 Million | -8 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 11.84 Million | 92 Thousand | 428.36 Million |
| Other Financing Activities | 11.84 Million | 92 Thousand | 8.05 Million |
| Accounts receivables | -205 Thousand | 47 Thousand | -19 Thousand |
| Accounts payables | 551 Thousand | 342 Thousand | 227 Thousand |
| Inventory | -10 Thousand | -194 Thousand | 55 Thousand |
| Other working capital | -1.29 Million | -355 Thousand | -345 Thousand |
| Cash at beginning of period | 183 Thousand | 1.12 Million | 134 Thousand |
| Cash at end of period | 4.21 Million | 183 Thousand | 1.12 Million |
| Capital Expenditure | -153 Thousand | -218 Thousand | -125 Thousand |
| Effect of forex changes on cash | -3000.00 | -7000.00 | -10 Thousand |
| Net cash flow / Change in cash | 4.03 Million | -938 Thousand | 987 Thousand |
| Free Cash Flow | -17.8 Million | -9.02 Million | -7.06 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.27 Million | -29.9 Million | -4.88 Million | 1.47 Million | -1.13 Million | 717.7 Thousand |
| Depreciation & Amortization | 34 Thousand | 133 Thousand | 48 Thousand | 29 Thousand | 29 Thousand | 27 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 123 Thousand | 1.57 Million | 1.57 Million | - | - | - |
| Change in working capital | -1.18 Million | -958 Thousand | -6.78 Million | 4.71 Million | -733.73 Thousand | 920 Thousand |
| Other non-cash items | 2.4 Million | 13 Million | 2 Million | -5.11 Million | 1.19 Million | -3.81 Million |
| Investing Cash Flow | -109 Thousand | -153 Thousand | -21 Thousand | -62 Thousand | 252 Thousand | 389.04 Million |
| Investments in PPE | -109 Thousand | -153 Thousand | -21 Thousand | -62 Thousand | -11 Thousand | -59 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | -389.3 Million | 252 Thousand | 389.04 Million |
| Other Investing Activities | -109 Thousand | - | - | 389.3 Million | - | - |
| Financing Cash Flow | 6.68 Million | 21.84 Million | -891 Thousand | 15.73 Million | 3 Million | 4 Million |
| Debt repayment | -5 Million | -10 Million | - | -3 Million | -3 Million | -4 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 387.6 Million | -2.00 | -387.6 Million |
| Common Stock Issuance | 1.68 Million | 11.84 Million | -891 Thousand | 12.73 Million | - | - |
| Other Financing Activities | 1.68 Million | 11.84 Million | -891 Thousand | 12.73 Million | 3 Million | - |
| Accounts receivables | 25 Thousand | -205 Thousand | -137 Thousand | -54 Thousand | 8000.00 | -22 Thousand |
| Accounts payables | -641 Thousand | 551 Thousand | -1.82 Million | 1.02 Million | 339 Thousand | 1.01 Million |
| Inventory | -140 Thousand | -10 Thousand | -30 Thousand | 14 Thousand | 6000.00 | 28 Thousand |
| Other working capital | -433 Thousand | -1.29 Million | -4.79 Million | 3.73 Million | -733.73 Thousand | 920 Thousand |
| Cash at beginning of period | 4.21 Million | 183 Thousand | 16.84 Million | 68 Thousand | 104.02 Thousand | 107.77 Thousand |
| Cash at end of period | 4.94 Million | 4.21 Million | 4.21 Million | 16.84 Million | 132.77 Thousand | 104.02 Thousand |
| Capital Expenditure | -109 Thousand | -153 Thousand | -21 Thousand | -62 Thousand | -11 Thousand | -59 Thousand |
| Effect of forex changes on cash | -1000.00 | -3000.00 | -2000.00 | -1000.00 | -1000.00 | 1000.00 |
| Net cash flow / Change in cash | 727 Thousand | 4.03 Million | -12.62 Million | 16.77 Million | 28.75 Thousand | -3753.00 |
| Free Cash Flow | -5.95 Million | -17.8 Million | -11.72 Million | 1.03 Million | -689.94 Thousand | -2.23 Million |
ICL
DSEEY
VSTO
CHTR
6094
NWHUF